Ahmed Lotfy (A Lotfy)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Angiotensin Converting Enzyme

Ischemia Reperfusion Injury

Top Venues

Stem cell research & therapy

Stem cell reviews and reports

Journal of clinical medicine

Stem cells international

This page only lists publications with an associated author ORCID identifier.

Publications

Ghada Maged, Menna A Abdelsamed, Hongjun Wang, Ahmed Lotfy
The potency of mesenchymal stem/stromal cells: does donor sex matter? Stem cell research & therapy 15 (1) (2024)
Ghada Maged, Menna A Abdelsamed, Hongjun Wang, Ahmed Lotfy
The potency of mesenchymal stem/stromal cells: does donor sex matter? Stem cell research & therapy 15 (1) (2024)
Ghada Maged, Menna A Abdelsamed, Hongjun Wang, Ahmed Lotfy
The potency of mesenchymal stem/stromal cells: does donor sex matter? Stem cell research & therapy 15 (1) (2024)
Ghada Maged, Menna A Abdelsamed, Hongjun Wang, Ahmed Lotfy
The potency of mesenchymal stem/stromal cells: does donor sex matter? Stem cell research & therapy 15 (1) (2024)
Ghada Maged, Menna A Abdelsamed, Hongjun Wang, Ahmed Lotfy
The potency of mesenchymal stem/stromal cells: does donor sex matter? Stem cell research & therapy 15 (1) (2024)
Ghada Maged, Menna A Abdelsamed, Hongjun Wang, Ahmed Lotfy
The potency of mesenchymal stem/stromal cells: does donor sex matter? Stem cell research & therapy 15 (1) (2024)
Ahmed Lotfy, Noha M AboQuella, Hongjun Wang
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials. Stem cell research & therapy 14 (1) (2023)
Anna Burdzińska, Marek Galanty, Sabina Więcek, Filip A Dabrowski, Ahmed Lotfy, Tomasz Sadkowski
The Intersection of Human and Veterinary Medicine-A Possible Direction towards the Improvement of Cell Therapy Protocols in the Treatment of Perianal Fistulas. International journal of molecular sciences 23 (22) (2022)
Ahmed Lotfy, Shimaa El-Metwaly, Reham Soliman, Ayman A Hassan, Gamal Shiha
Umbilical Cord Mesenchymal Stem/Stromal Cells and Low-Dose Obeticholic Acid as a Possible Combined Treatment for Liver Fibrosis. Stem cell reviews and reports 18 (5) (2022)
Ahmed Lotfy, Hongjun Wang
Immune Checkpoint Inhibitors and Mesenchymal Stem/Stromal Cells Combination Therapy Might Offer a Promising Treatment Option for Cancer. Stem cell reviews and reports (2022)
Ahmed Lotfy, Aya Elgamal, Anna Burdzinska, Ayman A Swelum, Reham Soliman, Ayman A Hassan, Gamal Shiha
Stem cell therapies for autoimmune hepatitis. Stem cell research & therapy 12 (1) (2021)
Mai Abdelgawad, Nourhan Saied Bakry, Ahmed A Farghali, Ahmed Abdel-Latif, Ahmed Lotfy
Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects. Stem cell research & therapy 12 (1) (2021)
Nourhan Saied Bakry, Mai Abdelgawad, Ahmed Abdel-Latif, Ahmed Lotfy
Mesenchymal stromal cells coated with anti-ACE2 antibodies might improve efficacy against COVID-19. Human cell (2021)
Ahmed Lotfy, Nourhan S Ali, Mai Abdelgawad, Mohamed Salama
Mesenchymal stem cells as a treatment for multiple sclerosis: a focus on experimental animal studies. Reviews in the neurosciences 31 (2) (2021)
Gamal Shiha, Ahmed Nabil Ahmed, Ahmed Lotfy, Reham Soliman, Ayman A Hassan, Islam S Ali, Doaa F Gad, Faten Zahran
Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis. Stem cells international 2020 (2020)
R J Cuthbert, E Jones, C Sanjurjo-Rodríguez, Ahmed Lotfy, P Ganguly, S M Churchman, P Castana, H B Tan, D McGonagle, Evangelia Papadimitriou, P V Giannoudis
Regulation of Angiogenesis Discriminates Tissue Resident MSCs from Effective and Defective Osteogenic Environments. Journal of clinical medicine 9 (6) (2020)